RS1 - Understanding Characteristics and Effects of Psychedelic-induced Experiences in the Clinical Setting

Tuesday, May 2, 2023

11:30 AM – 12:30 PM

Location: 502 A, Level 2, LACC

Matt Young, PhD, faculty for this educational event, is an Owner of Stock for Axsome Therapeutics. All relevant financial relationships listed for this individual have been mitigated.

Workshop Presenter(s)

Matt Young, Ph.D

Senior Medical Science Liaison
Compass Pathways, Inc
Chandler, Arizona

Slides

Despite growing interest in the potential clinical use of psychedelic compounds in treating mental health conditions, there is little familiarity with what a psychedelic-induced experience is. This presentation will provide a framework for characterizing acute psychedelic-induced experiences and explore clinical data to identify characteristics of those experiences that may contribute to observed clinical effects.

Learning Objectives:

Utilize the 5D-ASC scale to understand and characterize subjective experiences of psychedelic-induced altered states of consciousness.
Identify pharmacological and non-pharmacological factors that contribute to the intensity and quality of psychedelic-induced experiences.
Examine evidence of the role of subjective psychedelic-induced experiences on proposed clinical outcomes.